TargetMol

Repaglinide

Product Code:
 
TAR-T1088
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1088-25mg25mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1088-1mL1 mL * 10 mM (in DMSO)£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1088-50mg50mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1088-100mg100mg£134.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1088-200mg200mg£152.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Repaglinide is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.
CAS:
135062-02-1
Formula:
C27H36N2O4
Molecular Weight:
452.59
Pathway:
Membrane transporter/Ion channel; Metabolism; DNA Damage/DNA Repair
Purity:
0.9966
SMILES:
c1ccc(c(c1)[C@@H](NC(=O)Cc1cc(c(cc1)C(=O)O)OCC)CC(C)C)N1CCCCC1
Target:
Potassium Channel; PPAR

References

1. Hansen AM, et al. Br J Pharmacol,2005, 144(4), 551-557. 2. Okada M, et al. Biochem J,2003, 375(Pt 1), 87-97. 3. Laghmich A, et al. Eur J Pharmacol,1998, 348(2-3), 265-270. 4. Ladri?re L, et al. Eur J Pharmacol. 1997 Sep 24;335(2-3):227-34.